PDL BIOPHARMA, INC. PDLI Income Statement

Pdl biopharma, inc. (PDLI)

Income statement / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Dec'10	Sep'10	Jun'10	Mar'10	Sep'09	Jun'09
Costs and Expenses
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenues
Royalty revenues
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	361,287	359,426	355,649	351,641	353,462	356,534	354,750	343,475	340,292	367,253	0	0	0
Interest revenue
-	-	83	837	-	2,337	3,030	8,327	13,036	17,744	22,471	25,014	26,897	30,404	32,507	33,009	34,632	36,202	41,856	45,836	49,483	48,020	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Product revenue
-	-	-	-	-	-	-	-	-	-	69,018	63,079	44,250	-	14,128	0	0	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Licenses Revenue
-	-	-	-	-	-	-	-	-	-	19,338	19,376	167	-	150	857	530	723	580	575	0	-	0	0	-	-	0	0	-	-	0	-	-	10,400	11,900	11,500	11,500	1,500	0	12,461	0	0	0
Revenues
54,056	54,757	73,454	97,187	166,288	198,110	221,027	215,878	313,138	320,060	318,516	309,405	186,617	244,301	355,867	426,847	543,866	590,448	529,465	569,441	594,127	581,225	579,865	515,449	501,217	456,260	432,946	417,999	395,383	380,880	361,287	359,826	356,049	362,041	365,362	368,034	366,250	344,975	340,292	379,714	0	0	0
Operating expenses
Cost of Revenue
52,679	53,619	42,625	39,518	41,694	48,460	54,921	48,560	38,551	30,537	16,697	11,132	6,617	4,065	0	0	0	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Amortization of intangible assets
0	-	0	0	0	-	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Business Exit Costs
0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Amortization of intangible assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	6,014	0	0	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and administrative
50,154	45,598	36,907	38,026	42,072	45,420	49,189	47,967	44,726	45,641	48,450	46,857	42,520	39,790	39,738	37,792	38,270	36,090	41,271	38,507	37,998	34,914	25,049	27,288	27,151	29,755	29,626	27,348	25,710	25,469	22,560	20,873	19,504	18,338	25,571	32,721	37,765	41,396	34,595	29,075	0	0	0
Selling and Marketing Expense
8,158	8,482	8,131	9,888	13,200	17,139	20,856	22,381	20,612	17,683	11,721	6,738	3,122	538	11	0	0	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Research and Development Expense
8,254	7,308	6,912	3,274	3,072	2,955	2,878	2,811	6,408	7,381	8,539	9,867	5,586	3,820	1,933	0	0	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Impairment of Intangible Assets, Finite-lived
-	-	0	0	-	-	0	0	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change in fair value of contingent consideration
-	-	-19,198	-18,896	-	-41,631	-25,433	-25,035	-1,693	349	-2,450	-1,067	-2,274	-3,716	2,083	0	0	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Acquisition-related costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total operating expenses
-	-	102,173	98,608	-	248,704	275,246	274,217	133,571	126,280	162,278	153,133	131,988	114,899	49,189	35,635	0	-	0	0	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating loss from continuing operations
-123,471	-99,814	-15,191	12,107	-63,105	-50,594	-54,219	-58,339	179,567	193,780	156,238	156,272	54,629	129,402	298,604	382,117	501,617	550,379	488,194	530,934	556,129	546,311	554,816	488,161	474,066	426,505	403,320	390,651	369,673	355,411	338,727	338,953	336,545	343,703	247,291	242,813	235,985	211,079	305,697	350,639	0	0	0
Non-operating expense, net
Interest and other income, net
4,669	6,030	6,178	6,299	6,025	6,065	5,804	4,461	3,361	1,659	910	834	687	588	478	403	395	368	402	390	351	315	-3,502	-3,524	-3,546	242	2,324	4,138	4,506	758	2,516	779	508	593	0	0	0	-	-	-	-	-	-
Interest and other income
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-
Interest expense
8,923	11,404	11,845	11,700	11,527	12,157	14,401	16,631	18,835	20,221	19,825	19,242	18,688	18,267	18,873	20,261	22,999	27,059	31,151	34,637	37,296	39,211	36,472	33,203	29,396	24,871	24,119	24,515	26,336	29,036	31,247	33,740	35,648	36,102	37,455	38,376	40,156	43,529	37,120	30,549	0	0	0
Unrealized Gain (Loss) on Investments
0	-	0	-	0	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Business Combination, Bargain Purchase, Gain Recognized, Amount
-	-	-	-	-	-	-	-	-	-	0	0	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gain (Loss) on Investments
-	-	0	0	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gain (Loss) on Extinguishment of Debt
0	-	0	-	0	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-6,143	-6,143	-6,143	-6,143	0	0	0	0	-	-	-	-	-	-	0	-	-	0	0	-	0	0
Total non-operating expense, net
12,791	26,074	12,782	40,850	-4,738	-5,328	-3,283	-9,132	-6,165	-9,253	-17,273	-14,490	-20,354	-20,032	-11,945	-13,408	-16,154	-20,241	-30,749	-34,247	-36,945	-45,039	-46,117	-42,870	-39,085	-24,629	-21,795	-20,377	-21,830	-28,278	-28,731	-32,961	-35,906	-36,275	-49,122	-52,360	-69,768	-60,709	-39,618	-27,193	0	0	0
Loss from continuing operations before income taxes
-110,680	-73,740	-2,409	52,957	-67,843	-55,922	-57,502	-67,471	173,402	184,527	138,965	141,782	34,275	109,370	286,659	368,709	485,463	530,138	457,445	496,687	519,184	501,272	508,699	445,291	434,981	401,876	381,525	370,274	347,843	327,133	309,996	305,992	300,639	307,428	210,696	202,980	178,744	150,370	250,770	305,975	0	0	0
Income tax benefit from continuing operations
-16,674	-3,049	12,244	24,088	11,070	12,937	5,300	155	68,293	73,826	60,880	70,525	19,309	45,711	112,146	138,641	181,279	197,343	170,153	176,619	185,325	179,028	180,434	163,036	151,039	137,346	128,679	125,078	122,887	115,464	108,793	107,448	105,611	108,039	74,709	72,720	68,332	58,496	88,030	106,187	0	0	0
Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
-109,319	-70,691	416	43,938	-63,844	-68,859	-62,802	-67,626	105,109	110,701	78,085	71,257	14,966	63,659	143,398	0	0	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Discontinued Operation, Tax Effect of Discontinued Operation
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income (Loss) Attributable to Noncontrolling Interest
-505	-280	-340	-158	-63	0	0	0	0	-47	9	6	6	53	-3	0	0	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income (Loss) Attributable to Parent
-108,814	-70,411	756	44,096	-63,781	-68,859	-62,802	-67,626	105,109	110,748	78,076	71,251	14,960	63,606	174,516	230,068	304,184	332,795	287,292	320,068	333,859	322,244	328,265	282,255	283,942	264,530	252,846	245,196	224,956	211,669	201,203	198,544	195,028	199,389	135,987	130,260	110,412	91,874	162,740	199,788	0	0	0
Income (Loss) from Continuing Operations, Per Basic Share
-0.26	-	-	-	-0.07	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Earnings Per Share [Abstract]
Basic (in Dollars per Share)
-0.26	-0.44	-0.16	-0.04	0.05	0.10	0.18	-0.76	0.01	0.14	0.14	0.39	0.04	-0.06	0.08	0.03	0.34	0.62	0.42	0.48	0.52	0.35	0.64	0.57	0.48	0.44	0.40	0.67	0.38	0.35	0.35	0.53	0.29	0.28	0.33	0.50	0.32	-0.23	0.32	0.42	0.22	0.39	-
Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic Share
0.00	-	-	-	0.12	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net income per diluted share (in Dollars per Share)
-0.26	-0.44	-0.16	-0.04	0.05	0.10	0.18	-0.76	0.01	0.14	0.14	0.39	0.04	-0.06	0.08	0.03	0.34	0.64	0.42	0.47	0.50	0.29	0.61	0.52	0.44	0.32	0.36	0.62	0.36	0.32	0.32	0.52	0.29	0.24	0.28	0.38	0.25	-0.15	0.24	0.30	0.15	0.29	-
Income (Loss) from Continuing Operations, Per Diluted Share
-0.26	-	-	-	-0.07	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Diluted Share
0.00	-	-	-	0.12	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Weighted average shares outstanding
Basic (in Shares)
122,896	114,454	112,986	118,285	128,799	141,109	143,171	146,923	151,473	151,031	151,146	155,654	163,745	163,872	163,856	163,791	163,701	163,611	163,560	163,544	162,829	161,174	160,268	160,256	151,198	139,879	139,848	139,825	139,816	279,306	139,715	139,683	139	139,682	139,680	139,650	139,640	-246,628	127,479	119,536	119	119,411	119,357
Diluted (in Shares)
122,896	114,454	112,986	118,285	128,799	138,950	144,224	146,923	152,579	152,325	152,317	156,394	163,992	164,619	164,285	164,029	163,835	154,678	163,742	165,384	170,412	183,747	166,894	177,228	164,571	181,454	154,593	152,224	149,101	293,632	149,626	142,213	140	166,731	167,019	186,060	189,954	-345,084	172,217	173,398	184	168,576	169,566
Cash dividends declared per common share (in Dollars per Share)
-	-	-	-	-	-	-	-	-	-	-	-	-	0.00	0.00	0.05	0.05	0.00	0.00	0.00	0.60	0.00	0.00	0.00	0.60	0.00	0.00	0.00	0.60	0.00	0.00	0.00	0.60	0.00	0.00	0.00	0.60	-0.50	0.50	0.00	1.00	0.00	-
Product Revenue [Member]
Revenue from Contract with Customer, Including Assessed Tax
85,094	85,835	70,884	74,926	88,850	105,448	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Queen et al. patents [Member]
Revenues
6	9	11	544	1,756	4,536	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Acquired rights [Member]
Revenues
-	-	14,862	33,181	-	85,256	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
License and other [Member]
Revenues
-2	-45	-129	-44	-71	533	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-